ABH Optics ApS, founded in 2022 and headquartered in Denmark, has introduced a groundbreaking solution to the eyewear industry with their claim of producing the world's thinnest prescription eyeglass lenses. Their innovative lenses, all less than 2 mm thick across all optical powers, shift the optical power from the lens to its coating, addressing a significant demand from spectacle users for improved aesthetics and comfort.
In 2024, ABH Optics secured a €1 million pre-seed funding from HTGF to finalize development and obtain a CE marking, a crucial step towards commercial success in the European market. The company's development is poised to disrupt traditional lens manufacturing by offering enhanced flexibility in frame choice and visual appeal. This venture represents an attractive opportunity for investors looking to enter or expand their footprint in the optical sector, supported by ABH Optics' unique meta-optics technology.